false
OasisLMS
ar,zh-CN,zh-TW,en,fr,de,hi,it,ja,es,ur
Login
Catalog
SCAI 2026 Angio-Derived Physiology: Data, Technolo ...
Historical and Comparative Data, Dr. Sutton
Historical and Comparative Data, Dr. Sutton
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The speaker reviews coronary physiology tools, focusing on angiography-based methods like FFR-angio and QFR. They explain how FFR-angio works, its image requirements, and how it compares with invasive physiology. Guidelines currently lag behind evidence, though European and U.S. documents acknowledge related validated technologies. Clinical outcomes matter most: a 2024 QFR trial failed noninferiority and showed higher MACE versus invasive FFR. In contrast, the PROVISION trial found FFR-angio noninferior for revascularization decisions, with similar MACE, lower costs, and less radiation. The speaker concludes FFR-angio is fast, useful in multivessel disease, and valuable in the cath lab.
Asset Caption
closed captions are computer-generated
Keywords
coronary physiology
FFR-angio
QFR
angiography-based methods
revascularization decisions
×
Please select your language
1
English